Prognostic role of interferon-lambda 3 in anti-MDA5-positive dermatomyositis-associated ILD.
Atsuki FukadaTomoyuki FujisawaHironao HozumiKeigo KodaTaisuke AkamatsuYoshiyuki OyamaYasuomi SatakeMitsuru NiwaYusuke KaidaHiroyuki MatsudaKoshi YokomuraNaoki KoshimizuMikio ToyoshimaShiro ImokawaDai HashimotoAkira YoshidaTakahisa GonoMasataka KuwanaYasuhiko YamanoYasuhiro KondohKeita YamashitaMasato MaekawaKazutaka MoriYusuke InoueHideki YasuiYuzo SuzukiMasato KarayamaKazuki FuruhashiNoriyuki EnomotoNaoki InuiTakafumi SudaPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2023)
Serum IFN-λ3 is a promising biomarker for identifying patients at high risk of poor outcomes in anti-MDA5 antibody-positive DM-ILD. This article is protected by copyright. All rights reserved.